Phase 3 Trial Shows Promise for Oral Antibiotic Tebipenem pivoxil hydrobromide in Treating Complicated UTIs Dr. Kamal Kant Kohli30 May 2025 9:15 PM ISTTopline results from the phase 3 PIVOT-PO trial have revealed that tebipenem pivoxil hydrobromide (HBr), an investigational oral carbapenem...
USFDA grants fast track designation to Wockhardt novel antibiotic WCK 6777 Ruchika Sharma8 Oct 2024 10:30 AM ISTMumbai: Wockhardt has announced that its unique once-a-day, β-lactam enhancer based MDR-active antibiotic, WCK 6777 (Ertapenem/Zidebactam) has...
DCGI nod to Orchid Pharma Antibiotic Drug Combination of Cefepime, Enmetazobactam (NCE) Ruchika Sharma6 Jun 2024 12:25 PM ISTNew Delhi: Chennai-based Pharma Company, Orchid Pharma, has received Drugs Controller General of India (DCGI) approval for the manufacturing and...
Pfizer Emblaveo gets European Commission marketing nod for patients with multidrug-resistant infections and limited treatment options Ruchika Sharma26 April 2024 12:58 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO (aztreonam-avibactam) for...
Cipla gets CDSCO nod to market novel antibiotic Plazomicin in India, to launch under brand name Zemdri Ruchika Sharma5 March 2024 12:11 PM ISTMumbai: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic...
FDA approves Exblifep for complicated UTI including pyelonephritis Dr. Kamal Kant Kohli1 March 2024 11:30 PM ISTThe US Food and Drug Administration (FDA) has approved Exblifep (cefepime/enmetazobactam) for treatment of complicated urinary tract infections...
Orchid Pharma bags USFDA nod for Enmetazobactam Ruchika Sharma24 Feb 2024 1:30 PM ISTThis New Drug Approval allows the use of Exblifep (Cefepime and Enmetazobactam) as an injection for the treatment of patients 18 years and older with...
CDSCO Panel grants Wockhardt's Protocol Amendment Proposal For Cefepime Zidebactam Dr. Divya Colin11 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
GSK, Spero Therapeutics ink pact for complicated urinary tract infections antibiotic Tebipenem pivoxil hydrobromide Ruchika Sharma25 Sept 2022 1:13 PM ISTGSK will receive an exclusive licence to develop and commercialise tebipenem pivoxil HBr in all countries except Japan and certain other Asian...
Spero Therapeutics urinary tract infection drug Tebipenem rejected by USFDA Ruchika Sharma28 Jun 2022 2:56 PM ISTThe drugmaker said on Monday it intends to promptly request a meeting with the health regulator.
Short antibiotics course as good as long one for pyelonephritis in children Dr. Kamal Kant Kohli5 May 2020 9:39 AM ISTCurrent national guidelines recommend treating children with pyelonephritis for 7 to 14 days of antibiotic therapy, yet data are lacking to suggest a...
